Chen Z - Search Results

1

An open, observational clinical study of neoadjuvant therapy in resectable stage III non-small cell lung cancer.

Qi Y, Gu L, Shen J, Yao Y, Zhao Y, Lu S, Chen Z. Qi Y, et al. Among authors: chen z. Front Oncol. 2023 Aug 16;13:1194100. doi: 10.3389/fonc.2023.1194100. eCollection 2023. Front Oncol. 2023. PMID: 37655106 Free PMC article.

2

[The study of peri-operative chemotherapy in stage I-IIIa NSCLC].

Liao ML, Zhou YZ, Ding JA, Ni GX, Zhao JM, Chen WH, Han BH, Shen J, Bai H, Chen ZW, Ji H, Wang HM, Zhou Z. Liao ML, et al. Among authors: chen wh, chen zw. Zhonghua Yi Xue Za Zhi. 2003 Jun 10;83(11):962-6. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12899797 Clinical Trial. Chinese.

3

[Incidence, time trend, survival, and predictive factors of lung cancer in Shanghai populations].

Liao ML, Chen ZW, Zheng Y, Wu CX, Lu S, Yu YF, Jian H, Cheng BJ. Liao ML, et al. Zhonghua Yi Xue Za Zhi. 2007 Jul 17;87(27):1876-80. Zhonghua Yi Xue Za Zhi. 2007. PMID: 17923007 Chinese.

4

[Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].

Xu YH, Chen ZW, Ye XY, Lu S. Xu YH, et al. Zhonghua Zhong Liu Za Zhi. 2008 Sep;30(9):716-9. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173920 Clinical Trial. Chinese.

5

Pemetrexed monotherapy versus pemetrexed plus platinum combination as second-line treatment for advanced non-small cell lung cancer.

Zhang YF, Chen ZW, Lu S. Zhang YF, et al. Chin Med J (Engl). 2009 Oct 20;122(20):2472-6. Chin Med J (Engl). 2009. PMID: 20079162

6

A cost-effectiveness analysis of docetaxel versus pemetrexed in second-line chemotherapy for stage IIIb or IV non-small cell lung cancer in China.

Yu YF, Chen ZW, Zhou Z, Song ZB, Li ZM, Jian H, Zhang YF, Lu S. Yu YF, et al. Among authors: chen zw. Chemotherapy. 2010;56(6):472-7. doi: 10.1159/000321016. Epub 2010 Nov 23. Chemotherapy. 2010. PMID: 21099219

7

[Comparison of the efficacy of nedaplatin combined with docetaxel and docetaxel alone as a second line treatment for advanced non-small cell lung cancer].

Gu LP, Shen SP, Chen ZW. Gu LP, et al. Zhonghua Zhong Liu Za Zhi. 2010 Dec;32(12):939-42. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21223805 Chinese.

8

[Short-term intermittent prophylactic administration of recombinant human thrombopoietin attenuates chemotherapy-induced thrombocytopenia in lung cancer patients].

Xu YH, Cheng BJ, Lu S, Jian H, Zhou Z, Chen ZW, Ye XY. Xu YH, et al. Among authors: chen zw. Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):395-9. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 21875475 Clinical Trial. Chinese.

9

Erlotinib as a salvage treatment for patients with advanced non-small cell lung cancer after failure of gefitinib treatment.

Song ZB, Yu YF, Chen ZW, Lu S. Song ZB, et al. Chin Med J (Engl). 2011 Aug;124(15):2279-83. Chin Med J (Engl). 2011. PMID: 21933557

10

Establishment of a biomarker model for predicting bone metastasis in resected stage III non-small cell lung cancer.

Zhou Z, Chen ZW, Yang XH, Shen L, Ai XH, Lu S, Luo QQ. Zhou Z, et al. Among authors: chen zw. J Exp Clin Cancer Res. 2012 Apr 26;31(1):34. doi: 10.1186/1756-9966-31-34. J Exp Clin Cancer Res. 2012. PMID: 22537906 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75,146 results

Search Page

Filters